Medical Developments International Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company operates through three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management for use in home or in hospitals; Penthrox, a prescription only medicine for pain in trauma; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, resuscitation kits, oxygen therapy masks, and resuscitators. The company also provides veterinary anaesthetic machines, including animal asthma chambers, animal silicone face masks, animal air cushion face masks, resuscitators, MDI tourniquets, vaporisers, animal anaesthetic machines, breathing monitors, autoclavable and disposable CO2 absorbers, and accessories for anaesthetic machines. It operates in Australia, Europe, North America, the Middle East, Asia, and South Africa. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.
|Primary activities||Pharmaceutical drug business and medical and veterinary equipment business.|
|Industry / Sector||Drug Manufacturers—Specialty & Generic / Healthcare|
|Full time employees||68|
|Mailing address||4 Caribbean Drive Scoresby VIC 3179 Australia|
|Phone / Fax||61 3 9547 1888 / 61 3 9547 0262|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
|22 Sep 2021||Annual Report to shareholders|
Medical Developments International paid $0.00 dividend and the ex-dividend date was 05 Mar 2020.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MVP dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
MVP's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Jan 2022, following are the company executives and directors listed on Medical Developments International.
|Mr. Brent MacGregor||Chief Exec. Officer||57||540.53k|
|Mr. Mark Edwards C.A., BAcc, CA||CFO & Company Sec.||246.33k|
|Matthew Cramer||Chief of Operations & Supply Chain|
|Thomas Materia||Head of Sales & Marketing|
|Tara Collier||Head of HR|
|Dr. Scott Courtney||Chief Scientific Officer|
|Michelle Bradney||Head of Medical Affairs|
|Wai Ng Chi||Head of Regulatory Affairs|
|Neil Issa||Head of Quality|
|Wayne Pearce||Head of Production|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Medical Developments International is and its enterprise value is .
The MVP's stocks Beta value is 1.12 making it 12% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Medical Developments International (MVP)
Medical Developments International (ASX:MVP) Frequently Asked Questions
1. What is Medical Developments International's Stock Symbol?
Medical Developments International trades on ASX under the ticker symbol "MVP".
2. What is Medical Developments International's stock price today?
One share of MVP stock can currently be purchased for approximately $4.62.
3. How can I contact Medical Developments International?
Medical Developments International's mailing address is 4 Caribbean Drive Scoresby VIC 3179 Australia. The company can be reached via phone at 61 3 9547 1888.
4. What is Medical Developments International's official website?
The official website of Medical Developments International is https://medicaldev.com.
5. Which share registry manages Medical Developments International's stock?
Medical Developments International's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.